-
Anderson, Rouphael, Widge, Jackson, Roberts, Makhene, Chappell, Denison, Stevens, Pruijssers, McDermott, Flach, Lin, Doria-Rose, O'Dell, Schmidt, Corbett, Swanson, Padilla, Neuzil, Bennett, Leav, Makowski, Albert, Cross, Edara, Floyd, Suthar, Martinez, Baric, Buchanan, Luke, Phadke, Rostad, Ledgerwood, Graham, Beigel, mRNA-1273 Study Group, 2020: Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults[J]. N Engl J Med, 383, 2427-2438. doi: 10.1056/NEJMoa2028436
-
Castells MC, Phillips EJ, 2021: Maintaining safety with SARS-CoV-2 vaccines[J]. N Engl J Med, 384, e37-. doi: 10.1056/NEJMc2100766
-
Castilow EM, Olson MR, Varga SM, 2007: Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease[J]. Immunol Res, 39, 225-239. doi: 10.1007/s12026-007-0071-6
-
Chen IC, Wang SM, Yu CK, Liu CC, 2013: Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice[J]. Med Microbiol Immunol, 202, 259-265. doi: 10.1007/s00430-013-0289-y
-
Durham ND, Agrawal A, Waltari E, Croote D, Zanini F, Fouch M, Davidson E, Smith O, Carabajal E, Pak JE, Doranz BJ, Robinson M, Sanz AM, Albornoz LL, Rosso F, Einav S, Quake SR, McCutcheon KM, Goo L, 2019: Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics[J]. Elife, 8, e52384-. doi: 10.7554/eLife.52384
-
Halstead SB, 2017: Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age[J]. Vaccine, 35, 6355-6358. doi: 10.1016/j.vaccine.2017.09.089
-
Haynes BF, Corey L, Fernandes P, Gilbert PB, Hotez PJ, Rao S, Santos MR, Schuitemaker H, Watson M, Arvin A, 2020: Prospects for a safe COVID-19 vaccine[J]. Sci Transl Med, 12, eabe0948-. doi: 10.1126/scitranslmed.abe0948
-
Knipe DM, Levy O, Fitzgerald KA, Muhlberger E, 2020: Ensuring vaccine safety[J]. Science, 370, 1274-1275. doi: 10.1126/science.abf0357
-
Koff WC, Williams MA, 2020: Covid-19 and immunity in aging populations - a new research agenda[J]. N Engl J Med, 383, 804-805. doi: 10.1056/NEJMp2006761
-
La Vecchia C, Negri E, Alicandro G, Scarpino V, 2020: Attitudes towards influenza vaccine and a potential COVID-19 vaccine in Italy and differences across occupational groups, September 2020[J]. Med Lav, 111, 445-448.
-
Lane S, MacDonald NE, Marti M, Dumolard L, 2018: Vaccine hesitancy around the globe: analysis of three years of WHO/UNICEF joint reporting form data-2015-2017[J]. Vaccine, 36, 3861-3867. doi: 10.1016/j.vaccine.2018.03.063
-
Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P, 2014: Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012[J]. Vaccine, 32, 2150-2159. doi: 10.1016/j.vaccine.2014.01.081
-
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A, 2020: A global survey of potential acceptance of a COVID-19 vaccine[J]. Nat Med, 27, 225-228.
-
Li P, Chen L, Liu Z, Pan J, Zhou D, Wang H, Gong H, Fu Z, Song Q, Min Q, Ruan S, Xu T, Cheng F, Li X, 2020: Clinical features and short-term outcomes of elderly patients with COVID-19[J]. Int J Infect Dis, 97, 245-250. doi: 10.1016/j.ijid.2020.05.107
-
Li D, Edwards RJ, Manne K, Martinez DR, Schäfer A, Alam SM, Wiehe K, Lu X, Parks R, Sutherland LL, Oguin TH, McDanal C, Perez LG, Mansouri K, Gobeil SMC, Janowska K, Stalls V, Kopp M, Cai F, Lee E, Foulger A, Hernandez GE, Sanzone A, Tilahun K, Jiang C, Tse LV, Bock KW, Minai M, Nagata BM, Cronin K, Gee-Lai V, Deyton M, Barr M, Von Holle T, Macintyre AN, Stover E, Feldman J, Hauser BM, Caradonna TM, Scobey TD, Moody MA, Cain DW, DeMarco CT, Denny TN, Woods CW, Petzold EW, Schmidt AG, Teng IT, Zhou T, Kwong PD, Mascola JR, Graham BS, Moore IN, Seder R, Andersen H, Lewis MG, Montefiori DC, Sempowski GD, Baric RS, Acharya P, Haynes BF, Saunders KO, 2021: The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates[J]. bioRxiv, , -. doi: 10.1101/2020.12.31.424729
-
Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, Tang H, Nishiura K, Peng J, Tan Z, Wu T, Cheung KW, Chan KH, Alvarez X, Qin C, Lackner A, Perlman S, Yuen KY, Chen Z, 2019: Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection[J]. JCI Insight, 4, e123158-. doi: 10.1172/jci.insight.123158
-
Lucia VC, Kelekar A, Afonso NM, 2020: COVID-19 vaccine hesitancy among medical students[J]. J Public Health, , -. doi: 10.1093/pubmed/fdaa230
-
Mallapaty S, 2021: Are COVID vaccination programmes working? Scientists seek first clues[J]. Nature, , -. doi: 10.1038/d41586-021-00140-w
-
Mega ER (2021) Trust in COVID vaccines is growing. https://www.nature.com/articles/d41586-021-00368-6. Accessed 10 Feb 2021
-
Meyer K, Banerjee A, Frey SE, Belshe RB, Ray R, 2011: A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection[J]. PLoS ONE, 6, e23699-. doi: 10.1371/journal.pone.0023699
-
Pardi N, Weissman D, 2017: Nucleoside modified mRNA vaccines for infectious diseases[J]. Methods Mol Biol, 1499, 109-121.
-
Pawelec G, Weng NP, 2020: Can an effective SARS-CoV-2 vaccine be developed for the older population?[J]. Immun Ageing, 17, 8-. doi: 10.1186/s12979-020-00180-2
-
Perfilyeva YV, Karalnik BV, Ostapchuk YO, Kali A, Tleulieva RT, Abdolla N, Krasnoshtanov VK, Belyaev NN, 2020: Age-related decline in vaccination efficacy: the potential role of myeloid derived suppressor cells[J]. Adv Gerontol, 33, 785-795.
-
Polack, Thomas, Kitchin, Absalon, Gurtman, Lockhart, Perez, Pérez, Moreira, Zerbini, Bailey, Swanson, Roychoudhury, Koury, Li, Kalina, Cooper, Frenck, Hammitt, Türeci, Nell, Schaefer, Ünal, Tresnan, Mather, Dormitzer, Şahin, Jansen, Gruber, C4591001 Clinical Trial Group, 2020: Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine[J]. N Engl J Med, 383, 2603-2615. doi: 10.1056/NEJMoa2034577
-
Ren JJ, Sun T, He Y, Zhang Y, 2019: A statistical analysis of vaccine-adverse event data[J]. BMC Med Inform Decis Mak, 19, 101-. doi: 10.1186/s12911-019-0818-8
-
Russell MS, Creskey M, Muralidharan A, Li C, Gao J, Chen W, Larocque L, Lavoie JR, Farnsworth A, Rosu-Myles M, Hashem AM, Yauk CL, Cao J, Van Domselaar G, Cyr T, Li X, 2019: Unveiling integrated functional pathways leading to enhanced respiratory disease associated with inactivated respiratory syncytial viral vaccine[J]. Front Immunol, 10, 597-. doi: 10.3389/fimmu.2019.00597
-
Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, Brachtendorf S, Lörks V, Sikorski J, Hilker R, Becker D, Eller AK, Grützner J, Boesler C, Rosenbaum C, Kühnle MC, Luxemburger U, Kemmer-Brück A, Langer D, Bexon M, Bolte S, Karikó K, Palanche T, Fischer B, Schultz A, Shi PY, Fontes-Garfias C, Perez JL, Swanson KA, Loschko J, Scully IL, Cutler M, Kalina W, Kyratsous CA, Cooper D, Dormitzer PR, Jansen KU, Türeci Ö, 2020: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses[J]. Nature, 586, 594-599. doi: 10.1038/s41586-020-2814-7
-
Shaw J, Stewart T, Anderson KB, Hanley S, Thomas SJ, Salmon DA, Morley C, 2021: Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system[J]. Clin Infect Dis, , -. doi: 10.1093/cid/ciab054
-
Spencer JP, Trondsen Pawlowski RH, Thomas S, 2017: Vaccine adverse events: separating myth from reality[J]. Am Fam Physician, 95, 786-794.
-
Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, Moodie Z, Westling T, Mascareñas C, Frago C, Cortés M, Chansinghakul D, Noriega F, Bouckenooghe A, Chen J, Ng SP, Gilbert PB, Gurunathan S, DiazGranados CA, 2018: Effect of dengue serostatus on dengue vaccine safety and efficacy[J]. N Engl J Med, 379, 327-340. doi: 10.1056/NEJMoa1800820
-
Stone CA Jr, Rukasin CRF, Beachkofsky TM, Phillips EJ, 2019: Immune-mediated adverse reactions to vaccines[J]. Br J Clin Pharmacol, 85, 2694-2706. doi: 10.1111/bcp.14112
-
Su S, Du L, Jiang S, 2021: Learning from the past: development of safe and effective COVID-19 vaccines[J]. Nat Rev Microbiol, 19, 211-219. doi: 10.1038/s41579-020-00462-y
-
Takada A, Feldmann H, Ksiazek TG, Kawaoka Y, 2003: Antibody-dependent enhancement of Ebola virus infection[J]. J Virol, 77, 7539-7544. doi: 10.1128/JVI.77.13.7539-7544.2003
-
Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, Peters CJ, Couch RB, 2012: Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus[J]. PLoS ONE, 7, e35421-. doi: 10.1371/journal.pone.0035421
-
Verger P, Scronias D, Dauby N, Adedzi KA, Gobert C, Bergeat M, Gagneur A, Dubé E, 2021: Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020[J]. Euro Surveill, 26, 2002047-.
-
Voysey, Clemens, Madhi, Weckx, Folegatti, Aley, Angus, Baillie, Barnabas, Bhorat, Bibi, Briner, Cicconi, Collins, Colin-Jones, Cutland, Darton, Dheda, Duncan, Emary, Ewer, Fairlie, Faust, Feng, Ferreira, Finn, Goodman, Green, Green, Heath, Hill, Hill, Hirsch, Hodgson, Izu, Jackson, Jenkin, Joe, Kerridge, Koen, Kwatra, Lazarus, Lawrie, Lelliott, Libri, Lillie, Mallory, Mendes, Milan, Minassian, McGregor, Morrison, Mujadidi, Nana, O'Reilly, Padayachee, Pittella, Plested, Pollock, Ramasamy, Rhead, Schwarzbold, Singh, Smith, Song, Snape, Sprinz, Sutherland, Tarrant, Thomson, Török, Toshner, Turner, Vekemans, Villafana, Watson, Williams, Douglas, Hill, Lambe, Gilbert, Pollard, Oxford COVID Vaccine Trial Group, 2020: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK[J]. Lancet, 397, 99-111.
-
Wang G, Wu C, Zhang Q, Yu B, LU J, Zhang S, Wu G, Wu Y, Zhong Y, 2020: Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 45, 542-548. doi: 10.1007/s11739-020-02517-7
-
Weycker D, Edelsberg J, Halloran ME, Longini IM Jr, Nizam A, Ciuryla V, Oster G, 2005: Population-wide benefits of routine vaccination of children against influenza[J]. Vaccine, 23, 1284-1293. doi: 10.1016/j.vaccine.2004.08.044
-
Winarski KL, Tang J, Klenow L, Lee J, Coyle EM, Manischewitz J, Turner HL, Takeda K, Ward AB, Golding H, Khurana S, 2019: Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics[J]. Proc Natl Acad Sci U S A, 116, 15194-15199. doi: 10.1073/pnas.1821317116
-
Yi C, Yi Y, Li J, 2020: mRNA Vaccines: possible tools to combat SARS-CoV-2[J]. Virol Sin, 35, 259-262. doi: 10.1007/s12250-020-00243-0
-
Yoda T, Katsuyama H, 2021: Willingness to receive COVID-19 vaccination in Japan[J]. Vaccines (basel), 9, 48-. doi: 10.3390/vaccines9010048
-
Zhang C, Maruggi G, Shan H, Li J, 2019: Advances in mRNA vaccines for infectious diseases[J]. Front Immunol, 10, 594-. doi: 10.3389/fimmu.2019.00594